enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Finasteride - Wikipedia

   en.wikipedia.org/wiki/Finasteride

   In the prostate, this reduces prostate volume, which improves BPH and reduces the risk of prostate cancer. Finasteride reduces prostate volume by 20 to 30% in men with benign prostatic hyperplasia. [75] Inhibition of 5α-reductase also reduces epididymal weight, and decreases motility and normal morphology of spermatozoa in the epididymis. [76]

3. 5mg Finasteride vs 1mg: What's the Difference for Hair Growth?

   www.aol.com/5mg-finasteride-vs-1mg-whats...

   Finasteride and Prostate Cancer Risks Finasteride has been shown to lower the overall risk of prostate cancer. However, some old research from 1993 suggested it might increase the risk of high ...

4. What are the Side Effects of Taking Finasteride for ... - AOL

   www.aol.com/side-effects-taking-finasteride-hair...

   The most recent development in this line of research came in 2019 when researchers found no increase in the number of prostate cancer deaths between the group that used finasteride and a control ...

5. Can Finasteride Lower Testosterone? (& Other Potential Side ...

   www.aol.com/finasteride-lower-testosterone-other...

   Research shows that 1mg doses of finasteride are unlikely to cause side effects and there’s no clear ... which may increase the risk of prostate cancer. Conversely, finasteride has been found to ...

6. 5α-Reductase inhibitor - Wikipedia

   en.wikipedia.org/wiki/5α-reductase_inhibitor

   They have also been explored in the treatment and prevention of prostate cancer. While the 5-ARI finasteride reduces the cancer risk by about a third, it also increases the fraction of aggressive forms of prostate cancer. Overall, there does not seem to be a survival benefit for prostate cancer patients under finasteride. [5]

7. 5α-Reductase - Wikipedia

   en.wikipedia.org/wiki/5α-Reductase

   Dutasteride inhibits 5α-reductase isoenzymes type 1 and 2 better than finasteride, leading to a more complete reduction in DHT at 24 weeks (94.7% versus 70.8%). [23] It also reduces intraprostatic DHT 97% in men with prostate cancer at 5 mg/day over three months. [24]